[go: up one dir, main page]

ZA200710541B - Topical ungual formulations - Google Patents

Topical ungual formulations

Info

Publication number
ZA200710541B
ZA200710541B ZA200710541A ZA200710541A ZA200710541B ZA 200710541 B ZA200710541 B ZA 200710541B ZA 200710541 A ZA200710541 A ZA 200710541A ZA 200710541 A ZA200710541 A ZA 200710541A ZA 200710541 B ZA200710541 B ZA 200710541B
Authority
ZA
South Africa
Prior art keywords
ungual
topical
formulations
ungual formulations
topical ungual
Prior art date
Application number
ZA200710541A
Other languages
English (en)
Inventor
Jones Stuart Allen
Brown Marc Barry
Turner Robert
Original Assignee
Medpharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medpharm Ltd filed Critical Medpharm Ltd
Publication of ZA200710541B publication Critical patent/ZA200710541B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200710541A 2005-06-06 2007-12-04 Topical ungual formulations ZA200710541B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0511499.6A GB0511499D0 (en) 2005-06-06 2005-06-06 Topical ungual formulations

Publications (1)

Publication Number Publication Date
ZA200710541B true ZA200710541B (en) 2009-05-27

Family

ID=34835209

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200710541A ZA200710541B (en) 2005-06-06 2007-12-04 Topical ungual formulations

Country Status (16)

Country Link
US (1) US20080207537A1 (xx)
EP (1) EP1888029A2 (xx)
JP (1) JP2008542349A (xx)
KR (1) KR20080027765A (xx)
CN (1) CN101203209A (xx)
AU (1) AU2006256593A1 (xx)
BR (1) BRPI0611115A2 (xx)
CA (1) CA2610605A1 (xx)
GB (1) GB0511499D0 (xx)
IL (1) IL187893A0 (xx)
MX (1) MX2007015424A (xx)
NO (1) NO20080068L (xx)
NZ (1) NZ563844A (xx)
RU (1) RU2408361C2 (xx)
WO (1) WO2006131721A2 (xx)
ZA (1) ZA200710541B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8333981B2 (en) * 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails
US9320921B2 (en) * 2008-12-22 2016-04-26 Karen C. Swenholt Nail fungus treatment and composition
WO2011079234A2 (en) 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation
BR112012023421B1 (pt) 2010-03-17 2021-09-14 Novaliq Gmbh Composição farmacêutica para tratamento de aumento de pressão intraocular
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
RU2587064C2 (ru) * 2011-02-11 2016-06-10 Моберг Фарма Аб Новая противогрибковая композиция
EP2707007B1 (en) * 2011-05-11 2018-03-07 Veloce BioPharma LLC Antifungal compositions for the treatment of nails
PL2714010T3 (pl) * 2011-05-25 2017-08-31 Novaliq Gmbh Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach
EP2714008B1 (en) * 2011-05-25 2016-12-14 Novaliq GmbH Pharmaceutical composition for administration to nails
AU2013211645B2 (en) 2012-01-23 2017-06-15 Novaliq Gmbh Stabilised protein compositions based on semifluorinated alkanes
CA3142049C (en) 2012-09-12 2023-08-29 Novaliq Gmbh Semifluorinated alkane compositions
CA2997744C (en) 2012-09-12 2019-12-31 Novaliq Gmbh Compositions comprising mixtures of semifluorinated alkanes
CA2918419C (en) 2013-07-23 2022-05-03 Novaliq Gmbh Stabilized antibody compositions
ITUB20153759A1 (it) 2015-09-21 2017-03-21 Federica Livieri Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo
DK3356313T3 (da) 2015-09-30 2020-07-20 Novaliq Gmbh 2-perfluorhexyloktan til oftalmisk indgivelse
WO2017055454A1 (en) 2015-09-30 2017-04-06 Novaliq Gmbh Semifluorinated compounds and their compositions
JP2019520357A (ja) 2016-06-23 2019-07-18 ノバリック ゲーエムベーハー 局所投与方法
WO2018054932A1 (en) 2016-09-22 2018-03-29 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
CN109906085B (zh) 2016-09-23 2024-03-08 诺瓦利克有限责任公司 含有环孢素的眼用组合物
PL3612228T3 (pl) 2017-04-21 2024-04-08 Dermaliq Therapeutics, Inc. Kompozycje jodu
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
SG11202002640YA (en) 2017-09-27 2020-04-29 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
CA3091308A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
RU2688658C1 (ru) * 2018-04-10 2019-05-22 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Противогрибковый полусинтетический полиеновый антибиотик, его водорастворимые соли и фармацевтические композиции на их основе
WO2019206956A1 (en) 2018-04-27 2019-10-31 Novaliq Gmbh Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
AU2019345929B2 (en) 2018-09-27 2022-02-03 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
CA3112504A1 (en) 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair
MY206642A (en) 2018-10-12 2024-12-30 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
US12397039B2 (en) 2019-02-13 2025-08-26 Novaliq Gmbh Compositions and methods for the treatment of ocular neovascularization
KR20210118571A (ko) * 2020-03-23 2021-10-01 제이씨코리아 주식회사 감압 점착제 조성물, 이를 포함하는 점착제, 상기 점착제를 포함하는 인조네일 및 네일용 스티커

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
FR2767686B1 (fr) * 1997-09-01 2004-12-17 Oreal Composition pour la teinture d'oxydation des fibres keratiniques comprenant du 2-chloro 6-methyl 3-aminophenol et deux bases d'oxydation, et procede de teinture
US6231840B1 (en) * 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
AU3212099A (en) * 1998-03-31 1999-10-18 Johnson & Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
US20030007939A1 (en) * 1998-07-31 2003-01-09 Howard Murad Pharmaceutical compositions and methods for managing dermatological conditions
RU2186565C2 (ru) * 2000-03-13 2002-08-10 Большаков Сергей Борисович Способ лечения грибковых инфекций ногтей (онихомикозов)
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US6664292B2 (en) * 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails

Also Published As

Publication number Publication date
US20080207537A1 (en) 2008-08-28
MX2007015424A (es) 2008-04-17
NO20080068L (no) 2008-03-05
EP1888029A2 (en) 2008-02-20
WO2006131721A2 (en) 2006-12-14
RU2408361C2 (ru) 2011-01-10
WO2006131721A3 (en) 2007-09-07
BRPI0611115A2 (pt) 2010-08-10
GB0511499D0 (en) 2005-07-13
JP2008542349A (ja) 2008-11-27
AU2006256593A1 (en) 2006-12-14
CA2610605A1 (en) 2006-12-14
KR20080027765A (ko) 2008-03-28
CN101203209A (zh) 2008-06-18
RU2007148974A (ru) 2009-07-20
NZ563844A (en) 2011-01-28
IL187893A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
ZA200710541B (en) Topical ungual formulations
ZA200803150B (en) Topical Formulations
GB2424581B (en) Formulations
PL1848403T3 (pl) Preparaty bioadhezyjne o działaniu miejscowym
GB0424891D0 (en) Topical compositions
IL185773A0 (en) Formulations
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
ZA200704763B (en) Topical nepafenac formulations
EP1951693A4 (en) SOLID FORMULATIONS
EP1957080A4 (en) TOPICAL GLUCOCORTICOSTEROID FORMULATIONS
GB0405197D0 (en) Topical ungual formulations
IL179208A0 (en) Intereferon formulations
GB0520388D0 (en) Formulations
GB0526322D0 (en) Formulations
GB0522917D0 (en) Formulations
GB0518878D0 (en) Formulations
GB0417248D0 (en) Formulations
GB0417226D0 (en) Formulations
GB0500915D0 (en) Novel formulations
GB0522828D0 (en) Novel formulations
GB0500912D0 (en) Novel formulations
GB0500913D0 (en) Novel formulations
GB0500917D0 (en) Novel formulations
GB0504106D0 (en) Novel formulations
GB0519090D0 (en) Novel formulations